5.20
price down icon13.76%   -0.83
after-market Dopo l'orario di chiusura: 5.03 -0.17 -3.27%
loading
Precedente Chiudi:
$6.03
Aprire:
$4.75
Volume 24 ore:
5.68M
Relative Volume:
4.22
Capitalizzazione di mercato:
$15.54M
Reddito:
-
Utile/perdita netta:
$-16.60M
Rapporto P/E:
-5.8427
EPS:
-0.89
Flusso di cassa netto:
$-23.48M
1 W Prestazione:
+21.21%
1M Prestazione:
+27.14%
6M Prestazione:
-60.02%
1 anno Prestazione:
-84.52%
Intervallo 1D:
Value
$4.60
$5.38
Intervallo di 1 settimana:
Value
$3.99
$9.82
Portata 52W:
Value
$3.09
$36.60

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
Nome
Briacell Therapeutics Corp
Name
Telefono
(604) 921-1810
Name
Indirizzo
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
Dipendente
12
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-28
Name
Ultimi documenti SEC
Name
BCTX's Discussions on Twitter

Confronta BCTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BCTX
Briacell Therapeutics Corp
5.20 15.54M 0 -16.60M -23.48M -0.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-02-14 Iniziato H.C. Wainwright Buy

Briacell Therapeutics Corp Borsa (BCTX) Ultime notizie

pulisher
Apr 27, 2025

(BCT) Trading Performance and Risk Management (BCT:CA) - news.stocktradersdaily.com

Apr 27, 2025
pulisher
Apr 26, 2025

BriaCell (BCTX) Prices Public Offering of Units to Raise $13.8 M - GuruFocus

Apr 26, 2025
pulisher
Apr 26, 2025

Increased Share Offering for XYZ Corp (XYZ) Priced Below Market - GuruFocus

Apr 26, 2025
pulisher
Apr 26, 2025

BriaCell Stock Dips After-Hours On Pricing $13.8M Public Offering, But Retail's Busy Cheering Clinical Milestone - MSN

Apr 26, 2025
pulisher
Apr 25, 2025

BriaCell Therapeutics (BCTX) Prices $13.8 Million Public Offerin - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

BriaCell's Stock Dips Following Public Offering Announcement - Finimize

Apr 25, 2025
pulisher
Apr 25, 2025

BriaCell Therapeutics Down 17% In US Premarket As Prices US$13.8 Million Public Offering - marketscreener.com

Apr 25, 2025
pulisher
Apr 25, 2025

BriaCell Therapeutics announces pricing of $13.8 million public offering - MSN

Apr 25, 2025
pulisher
Apr 24, 2025

(BCT) Trading Report (BCT:CA) - news.stocktradersdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering | BCTX Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Stock Dips After-Hours On Pricing $13.8M Public Offering, But Retail’s Busy Cheering Clinical Milestone - Investing.com India

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Therapeutics Announces $13.8 Million Public Offering - TipRanks

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Raises $13.8M: Strong Institutional Demand Drives Full Exercise of Underwriter Option - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Briacell Therapeutics Says Units Priced At $4.50 Each For Gross Proceeds Of $13.8 Million - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell reports complete lung metastasis resolution in breast cancer study By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell's Bria-OTS shows sustained success against breast cancer | 2025-04-24 | Investing News - Stockhouse

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell confirms 100% resolution of lung metastasis with Bria-OTS - TipRanks

Apr 24, 2025
pulisher
Apr 24, 2025

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell (BCTX) Showcases Key Breast Cancer Trial Data at ASCO 2 - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell (BCTX) Reports Positive Outcomes in Bria-OTS Cancer Study | BCTX Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell’s Bria-OTS Shows Promising Results in Metastatic Breast Cancer Study - TipRanks

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Therapeutics stock soars on lung metastasis treatment success By Investing.com - Investing.com Nigeria

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell reports complete lung metastasis resolution in breast cancer study - Investing.com India

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Therapeutics stock soars on lung metastasis treatment success - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™ | BCTX Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™ - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

Breakthrough: BriaCell's Novel Cancer Treatment Eliminates Lung Metastasis in Advanced Breast Cancer Patient - Stock Titan

Apr 24, 2025
pulisher
Apr 23, 2025

H.C. Wainwright maintains $32 target on BriaCell stock - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

H.C. Wainwright maintains $32 target on BriaCell stock By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

BriaCell Therapeutics Corp. - Baystreet.ca

Apr 23, 2025
pulisher
Apr 23, 2025

Stocks In Play: BriaCell Therapeutics Corp. - Barchart.com

Apr 23, 2025
pulisher
Apr 23, 2025

BriaCell Announces Four Clinical Data Presentations at ASCO 2025 - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

BriaCell to Present Key Clinical Data at ASCO 2025 - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

BriaCell Announces Four Clinical Data Presentations at ASCO 2025 | BCTX Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Major Phase III Breast Cancer Treatment Update: BriaCell Unveils 4 Clinical Studies at ASCO 2025 - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Briacell Therapeutics Files For Offering Of Up To 2.3 Mln Common Units, Up To 2.3 Mln Pre-Funded Units - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

Innovative Company Announces New Common Unit Offering | BCTX Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

BriaCell Enrollment Accelerates In Phase 3 Study For Advanced Metastatic Breast Cancer - Nasdaq

Apr 22, 2025
pulisher
Apr 22, 2025

BriaCell Advances Phase 3 Study in Metastatic Breast Cancer - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

BriaCell (BCTX) Advances Phase 3 Trial for Bria-IMT in Metastatic Breast Cancer | BCTX Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC) - GlobeNewswire

Apr 22, 2025

Briacell Therapeutics Corp Azioni (BCTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):